Pharma Journalist -

Samsung Bioepis Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved ONTRUZANT (trastuzumab-dttb), a biosimilar referencing HERCEPTIN (trastuzumab), across…
Read More...

The Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) today voted eight to eight on the question of whether the overall benefits of…
Read More...

Pharma Regulatory Summit is the leading platform for regulatory experts, to be updated with latest country updates and strategies to navigate the complex and ever changing regulations…
Read More...

SMi Reports: Biotech Genentech, discoverers of a promising new antibiotic, are set to speak at this year’s Superbugs & Superdrugs Conference in London, UK on 18th - 19th March 2019.…
Read More...

SMi reports: As the 3rd Annual Highly Potent Active Pharmaceutical Ingredients conference returns to London in May 2019, industry professionals are set to discuss overcoming the latest…
Read More...

AstraZeneca announced that its partner Ironwood Pharmaceuticals, Inc. has received marketing authorisation from the National Medical Products Administration (NMPA) for Linzess…
Read More...

The SCHOTT technology group is set to invest around 300 million euros in the next three years in the expansion of its core business of glass tubing as the starting material for…
Read More...

AMAG Pharmaceuticals announced that it has completed the previously announced acquisition of Perosphere Pharmaceuticals Inc., a private biopharmaceutical company. Through this…
Read More...

Pfizer Inc. announced that the US Food and Drug Administration (FDA) accepted for filing the company’s New Drug Applications (NDAs) for tafamidis for the treatment of transthyretin…
Read More...

BioMed X announced a new crowdsourcing project within its framework collaboration with Boehringer Ingelheim. BioMed X and Boehringer Ingelheim started their partnership in 2014 and…
Read More...